Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co KGaA    FRE   DE0005785604

Delayed Quote. Delayed  - 09/28 05:35:25 pm
71.35 EUR   +0.65%
09/22FRESENIUS SE & : The upward trend should continue
09/05DJFRESENIUS : to Buy Spanish Hospital Group Quironsalud for 5.76 Billi..
09/01DJNestlé Strikes Deal to Acquire Phagenesis
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Fresenius Sets Pricing On EUR500 Million 7-Year Bond At 4.25% Area

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/21/2012 | 01:24pm CEST

("Fresenius Sets Pricing On EUR500M 7-Year Bond At 4.25% Area," at 1020 GMT, misstated the vehicle issuing the bond in the first paragraph. The correct version follows:)

-German medical care company Fresenius SE & CO. KGaA (>> Fresenius SE & Co KGaA) has set price guidance on its EUR500 million seven-year bond in the area of 4.25%, one of the banks on the deal said Wednesday.

The issue will be priced later Wednesday, and books on the deal are comfortably oversubscribed, said one of the banks on the deal. The issue was primarily targeted at retail accounts, which showed a good deal of interest, it added.

The bond will be used--among other corporate purposes--to fund the acquisition of hospital operator Damp Group, which Fresenius acquired in October 2011.

Expected ratings are Ba1 from Moody's Investors Service and BB+ from Standard & Poor's Corp. and Fitch Ratings.

Royal Bank of Scotland Group PLC, Deutsche Bank AG, Commerzbank AG, LBBW and Bayern LB are lead managers on the deal.

-By Serena Ruffoni, Dow Jones Newswires; +44 (0) 207 842 9349; serena.ruffoni@dowjones.com

Stocks mentioned in the article : Fresenius SE & Co KGaA
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO KGAA
09/05DJFRESENIUS : to Buy Spanish Hospital Group Quironsalud for 5.76 Billion Euros
09/05 DGAP-ADHOC : Fresenius SE & Co. KGaA: Fresenius Helios erwirbt Spaniens größte p..
09/05 DGAP-ADHOC : Fresenius SE & Co. KGaA: Fresenius Helios acquires largest private ..
09/01DJNestlé Strikes Deal to Acquire Phagenesis
09/01 ULF MARK SCHNEIDER : Nestle to buy medical device company Phagenesis in stages
08/31 DGAP-NVR : Fresenius SE & Co. KGaA: Release according to Article 26a of the WpHG..
08/31 DGAP-NVR : Fresenius SE & Co. KGaA: Veröffentlichung der Gesamtzahl der Stimmrec..
08/30 FRESENIUS : Hamilton County Emergency Communications District reaccredited
08/18DJNestlé Reports Subdued Sales Growth
08/18 FRESENIUS : Baldwin Borough councilman raps cost of police department's accredit..
More news
Sector news : Hospitals, Clinics & Primary Care Services
09/16 FTSE falls as banking stocks lose ground
09/14DJBusiness Watch -- WSJ
09/13DJUNITEDHEALTH : Optum Unit to Oversee Quest Diagnostics' Billing Processes
09/13DJUNITEDHEALTH : Optum Unit to Oversee Quest Diagnostic's Billing Processes
09/02DJFRESENIUS MEDICAL CARE : Buys Indian Dialysis Service Provider Sandor Nephro
More sector news : Hospitals, Clinics & Primary Care Services
News from SeekingAlpha
09/20 A Unique Method To Value Dividend Stocks Based On Expected Growth
08/07 Fresenius SE & Co. KGaA ADR 2016 Q2 - Results - Earnings Call Slides
08/07 Fresenius' Cempra's (FSNUY) CEO Stephan Sturm on Q2 2016 Results - Earnings C..
07/01 A NEW SOURCE FOR DIVIDEND GROWTH INV : The German Dividend Aristocrats
06/27 Nestle appoints Fresenius?s Schneider as new CEO
Advertisement
Financials (€)
Sales 2016 29 194 M
EBIT 2016 4 365 M
Net income 2016 1 603 M
Debt 2016 13 207 M
Yield 2016 0,87%
P/E ratio 2016 24,28
P/E ratio 2017 21,56
EV / Sales 2016 1,78x
EV / Sales 2017 1,63x
Capitalization 38 752 M
More Financials
Chart FRESENIUS SE & CO KGAA
Duration : Period :
Fresenius SE & Co KGaA Technical Analysis Chart | FRE | DE0005785604 | 4-Traders
Full-screen chart
Technical analysis trends FRESENIUS SE & CO...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 75,7 €
Spread / Average Target 6,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stephan Sturm Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Niko Stumpfögger Member-Supervisory Board
Dario Anselmo Ilossi Member-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO KGAA7.46%43 509
IHH HEALTHCARE BHD--.--%12 871
RAMSAY HEALTH CARE LIM..16.34%12 243
BANGKOK DUSIT MEDICAL ..--.--%9 945
MEDICLINIC INTERNATION..17.46%8 903
AIER EYE HOSPITAL GROU..--.--%5 286
More Results